China Biologic Products Holdings, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was USD 138.535 million compared to USD 136.106 million a year ago. Operating income was USD 52.015 million compared to USD 52.993 million a year ago. Net income was USD 39.544 million compared to USD 47.016 million a year ago. Basic earnings per share from continuing operations was USD 1.02 compared to USD 1.21 a year ago. Diluted earnings per share from continuing operations was USD 0.99 compared to USD 1.21 a year ago. For the nine months, total revenue was USD 412.239 million compared to USD 401.587 million a year ago. Operating income was USD 162.732 million compared to USD 145.051 million a year ago. Net income was USD 128.610 million compared to USD 126.356 million a year ago. Basic earnings per share from continuing operations was USD 3.31 compared to USD 3.22 a year ago. Diluted earnings per share from continuing operations was USD 3.24 compared to USD 3.21 a year ago.